author-photo

Rosemary Morrison

University of Glasgow

4

Papers

818

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

A phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors

2008 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (125)
A phase 1, pharmacokinetic (PK) and pharmacodynamic (PD) study of CHIR-258, a novel oral multiple receptor tyrosine kinase (RTK) inhibitor

2006 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
A dose-finding and pharmacokinetic study of the matrix metalloproteinase inhibitor MMI270 (previously termed CGS27023A) with 5-FU and folinic acid

2005 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (24)
Phase I Clinical and Pharmacokinetic Study of PK1 [N-(2-Hydroxypropyl)methacrylamide Copolymer Doxorubicin]: First Member of a New Class of Chemotherapeutic Agents—Drug-Polymer Conjugates

1999 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (667)